 |
SYDNEY, March 2, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into an exclusive worldwide license agreement with Oasmia Pharmaceutical AB (STO: OASM), an innovation-focused specialty pharmaceutical company, for Cantrixil...
A résumé tells an employer where you have studied, where you have worked and what qualifications you hold. What it cannot ...
For many Australians, an investment property is the most familiar example of a capital gains tax event. Buy a property, hol...
Every generation of business leaders faces its defining challenge. For some, it was rebuilding after war. For others, it w...
Buying a new car has become more complicated than choosing between petrol and diesel. Today's buye...
Fremantle Ports has partnered with Byssal and DevelopmentWA to trial an innovative nature-based pilo...
Buying a new car has become more complicated than choosing between petrol and diesel. Today's buye...
For years, Phong Nha in central Vietnam has attracted adventurous travellers drawn by its spectacu...
For years, Phong Nha in central Vietnam has attracted adventurous travellers drawn by its spectacu...
The word "fatphobia" has become increasingly common in discussions about health, body image and so...
A résumé tells an employer where you have studied, where you have worked and what qualifications y...